Mark J. Mulligan
NYU Langone Health(US)New York University(US)
Publications by Year
Research Areas
SARS-CoV-2 and COVID-19 Research, HIV Research and Treatment, COVID-19 Clinical Research Studies, Influenza Virus Research Studies, Immunotherapy and Immune Responses
Most-Cited Works
- → Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates(2020)2,701 cited
- → Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults(2020)1,576 cited
- → Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans(2008)1,110 cited
- → Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection(2011)799 cited
- → Molecular signatures of antibody responses derived from a systems biology study of five human vaccines(2013)791 cited
- → Human Effector and Memory CD8+ T Cell Responses to Smallpox and Yellow Fever Vaccines(2008)609 cited